المؤلفون: Arif Hakan Onder, Banu Ozturk, Murat Kocer, Deniz Ozbay Gediz, Derya Kivrak Salim, Mustafa Yildiz, Selami Bayram, Sevil Goktas

المصدر: Medicine Science, Vol 12, Iss 3, Pp 827-52 (2023)

مصطلحات موضوعية: self-ecog-ps, promis anxiety, promis depression, charlson comorbidity index, hollingshead index, Medicine

وصف الملف: electronic resource

Relation: https://www.medicinescience.org/?mno=160903; https://doaj.org/toc/2147-0634

URL الوصول: https://doaj.org/article/69b5fb7a86fd46b99e2afca49d9a1cce

المؤلفون: Arif Hakan ONDER, Derya KIVRAK SALİM, Mustafa KARACA, Selami BAYRAM, Armağan AYDIN, Sevil GÖKTAŞ, Murat KOÇER, Deniz ÖZBAY GEDİZ, Mustafa YILDIZ, Banu ÖZTÜRK

المصدر: Volume: 44, Issue: 4 384-389
Cumhuriyet Tıp Dergisi
Cumhuriyet Medical Journal

مصطلحات موضوعية: Health Care Sciences and Services, Anxiety, cancer, Covid-19, depression, ENGAGe, fear, General Medicine, Sağlık Bilimleri ve Hizmetleri

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a899aeff6854bbc60d8d81c9244488d6
https://dergipark.org.tr/tr/pub/cmj/issue/74897/1210488

المؤلفون: Yusuf Ilhan, Ali Murat Tatli, Fatih Teker, Arif Hakan Onder, Fatih Kose, Caglayan Geredeli, Mustafa Karaagac, Muhammet Ali Kaplan, Mevlude Inanc, Sabin Goktas Aydin, Aysegul Kargi, Hacı Arak, Banu Ozturk, Ali Ayberk Besen, Oguzhan Selvi, Mustafa Korkmaz, Zeynep Oruc, Oktay Bozkurt, Ahmet Bilici, Selami Bayram, Shute Ailia Dae, Mustafa Ozdogan, Hasan Senol Coskun, Sema Sezgin Goksu

المساهمون: Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Medikal Onkoloji Ana Bilim Dalı, Kaplan, Muhammet Ali, Oruç, Zeynep

مصطلحات موضوعية: Paclitaxel, Uterine Cervical Neoplasms, Obstetrics and Gynecology, Cervical Cancer, Carboplatin, Bevacizumab, Oncology, Antineoplastic Combined Chemotherapy Protocols, Cervical cancer, Humans, Female, Versus Carboplatin Plus, Neoplasm Recurrence, Local, Cisplatin, Retrospective Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7a43bb00c7770acf17bbd73232c4c59
https://hdl.handle.net/20.500.12511/9393

المؤلفون: Ayhan Hilmi Çekin, Mustafa Yildiz, Murat Koçer, Selami Bayram, Ismail Gomceli, Mustafa Karaca, Derya Kıvrak Salim

المصدر: The Turkish Journal of Gastroenterology. 30:910-916

مصطلحات موضوعية: Male, medicine.medical_specialty, Neuroendocrine tumors, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Unresected, Stomach Neoplasms, Internal medicine, Intestinal Neoplasms, medicine, Humans, Survival rate, Aged, Proportional Hazards Models, Retrospective Studies, biology, Proportional hazards model, business.industry, Palliative Care, Hazard ratio, Chromogranin A, Retrospective cohort study, Middle Aged, Prognosis, medicine.disease, Primary tumor, Pancreatic Neoplasms, Survival Rate, Neuroendocrine Tumors, 030220 oncology & carcinogenesis, biology.protein, Original Article, Female, 030211 gastroenterology & hepatology, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::632d49cf505aa4978a96ad544252f110
https://doi.org/10.5152/tjg.2019.19168

المؤلفون: Mehmet Artac, Ozgur Tanriverdi, Osman Kostek, Ahmet Dirican, Özge Keskin, Nail Paksoy, Ali Alkan, Müge Sönmez, Mustafa Yildirim, Şeyda Gündüz, Zuhat Urakci, Ahmet Taner Sümbül, Semra Paydas, Kerem Oruc, Deniz Tural, Birol Yildiz, Ali Osman Kaya, Burcu Çakar, Meltem Ekenel, Fatih Selcukbiricik, Irem Bilgetekin, Fatma Paksoy Turkoz, Yuksel Urun, Mustafa Erman, Meltem Selam, Nail Özhan, Ömer Fatih Ölmez, Halil Taskaynatan, Saadettin Kilickap, Elif Atag, Selami Bayram, Deniz Tataroğlu Özyükseler, Dilek Erdem, Sabri Güncan, Tugba Basoglu, Mehmet Ali Nahit Sendur, Hasan Şenol Coşkun

المساهمون: İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Fatma Paksoy Türköz / 0000-0002-2314-263X, Saadettin Kılıçkap / 0000-0003-1637-7390, Paksoy Türköz, Fatma, Kılıçkap, Saadettin

مصطلحات موضوعية: 0301 basic medicine, Oncology, Survival, retrospective study, Trial, hazard ratio, primary tumor, 0302 clinical medicine, Surgical oncology, transitional cell carcinoma, creatinine clearance, Atezolizumab, Cancer, Univariate analysis, adult, Hazard ratio, Hematology, General Medicine, Bladder Cancer, univariate analysis, aged, female, multivariate analysis, 030220 oncology & carcinogenesis, Immunotherapy, Plus, medicine.medical_specialty, Metastatic Urothelial Carcinoma, overall survival, tumor localization, Renal function, medical record, cancer prognosis, Article, cancer growth, 03 medical and health sciences, evaluation study, male, Internal medicine, medicine, follow up, human, lymphocyte count, Bladder cancer, hemoglobin blood level, Performance status, ECOG Performance Status, business.industry, neutrophil count, Urothelial Carcinoma, hemoglobin, medicine.disease, major clinical study, neutrophil lymphocyte ratio, liver metastasis, 030104 developmental biology, Surgery, Therapy, Cisplatin, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ad0808c1ae34df687e136a5aa5ec7ca
https://avesis.deu.edu.tr/publication/details/8d62a86a-0e4f-4339-9426-b0070cd55957/oai

المؤلفون: Mustafa Yildirim, Meliha Saatçi, Yusuf Ilhan, Mustafa Yildiz, Hasan Mutlu, Dilhun Şahin, Hasan Şenol Coşkun, Sema Sezgin Goksu, Hakan Bozcuk, Ayberk Ouisupov, Gözde Yalçın, Alev Aydeniz, Murat Koçer, Tahir Yerlikaya, Mehmet Artac, Muzaffer Uğraklı, Selami Bayram

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(3)

مصطلحات موضوعية: Chemotherapy, business.industry, medicine.medical_treatment, External validation, Cancer, medicine.disease, Logistic regression, External validity, Oncology, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, medicine, Cutoff, Humans, Derivation, Prospective Studies, business, Algorithm, Febrile neutropenia, Algorithms, Febrile Neutropenia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50632bbbb5588b45a9eb88c8559e8359
https://pubmed.ncbi.nlm.nih.gov/34816328

المؤلفون: Ahmet Taner Sümbül, Osman Kostek, Deniz Tural, Fatma Paksoy Turkoz, Şeyda Gündüz, Mehmet Artac, Ömer Fatih Ölmez, Mustafa Yildirim, Dilek Erdem, Ali Osman Kaya, Yuksel Urun, Meltem Ekenel, Birol Yildiz, Ali Alkan, Emre Akar, Nail Özhan, Halil Taskaynatan, Özge Keskin, Mehmet Ali Nahit Sendur, Deniz Tataroğlu Özyükseler, Zuhat Urakci, Nail Paksoy, Ozgur Tanriverdi, Sabri Güncan, Ugur Yilmaz, Irem Bilgetekin, Elif Atag, Kerem Oruc, Mustafa Erman, Meltem Selam, Hasan Şenol Coşkun, Ahmet Dirican, Müge Sönmez, Tugba Basoglu, Selami Bayram, Burcu Çakar, Fatih Selcukbiricik, Semra Paydas, Saadettin Kilickap

المساهمون: Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Ana Bilim Dalı, Urakçı, Zuhat, Ege Üniversitesi

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Urologic Neoplasms, Metastatic Urothelial Carcinoma, Survival, Urology, education, 030232 urology & nephrology, Antibodies, Monoclonal, Humanized, Trial, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, medicine, Clinical endpoint, Humans, Adverse effect, Multicenter, reproductive and urinary physiology, health care economics and organizations, Retrospective Studies, Carcinoma, Transitional Cell, Bladder cancer, business.industry, medicine.disease, Chemotherapy regimen, humanities, Clinical trial, Urinary Bladder Neoplasms, 030220 oncology & carcinogenesis, Expanded access, Urothelial carcinoma, Therapy, Immunotherapy, Cisplatin, Plus, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dc593e73ea82bc330c89132a0963f04
https://doi.org/10.1016/j.euf.2020.09.010

المؤلفون: Birol Yildiz, Mehmet Ali Nahit Sendur, Ugur Yilmaz, Osman Kostek, Meltem Ekenel, Burcu Çakar, Fatih Selcukbiricik, Ahmet Taner Sümbül, Selami Bayram, Deniz Tural, Fatma Paksoy Turkoz, Irem Bilgetekin, Kerem Oruc, Emre Akar, Mehmet Artac, Ömer Fatih Ölmez, Nail Özhan, Hasan Şenol Coşkun, Mustafa Erman, Özge Keskin

المصدر: Journal of Clinical Oncology. 39:409-409

مصطلحات موضوعية: Response rate (survey), Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, Metastatic Urothelial Carcinoma, business.industry, medicine.medical_treatment, Atezolizumab in Patients, First-Line Chemotherapy, Atezolizumab, Internal medicine, medicine, Overall survival, In patient, First line chemotherapy, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f675e8dcf114840d0d66811712938516
https://doi.org/10.1200/jco.2021.39.6_suppl.409

المؤلفون: Fatma Paksoy Turkoz, Emre Akar, Ömer Fatih Ölmez, Özge Keskin, Mehmet Artac, Burcu Çakar, Osman Kostek, Fatih Selcukbiricik, Nail Paksoy, Selami Bayram, Kerem Oruc, Ahmet Taner Sümbül, Deniz Tural, Irem Bilgetekin, Nail Özhan, Saadettin Kilickap, Mustafa Erman, Birol Yildiz, Ugur Yilmaz, Hasan Şenol Coşkun

المصدر: Journal of Clinical Oncology. 38:451-451

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Metastatic Urothelial Carcinoma, business.industry, Locally advanced, Clinical trial, Safety profile, Atezolizumab, Internal medicine, Chemotherapy, Medicine, In patient, First line chemotherapy, Real-Life Experience, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5f486427ab2a392ce34f56186bec799
https://doi.org/10.1200/jco.2020.38.6_suppl.451